RNA based COVID-19 vaccine / VLP Therapeutics - LARVOL DELTA

Fujifilm signs manufacturing contract with U.S. firm VLP for Covid-19 vaccine (The Economic Times) - "Fujifilm Holdings Corp said on Thursday that it had signed a manufacturing contract agreement with U.S.-based firm VLP Therapeutics for a Covid-19 vaccine formulation. Japan's Fujifilm will use its manufacturing facilities and infrastructure to handle development of the vaccine for clinical trials....VLP's RNA-based vaccine candidate was selected for funding by the Japan Agency for Medical Research and Development."

Licensing / partnership • Infectious Disease • Novel Coronavirus Disease